-
Spinoffs Are Outperforming Parent Companies
Thursday, July 7, 2016 - 1:47pm | 457Read More...In a recent tweet, CNBC Senior Markets Commentator Michael Santoli pointed out how WhiteWave Foods Co (NYSE: WWAV) stock is now up 215.8 percent since its May 2013 spinoff from parent company Dean Foods Co (NYSE: DF), which is down 5.9 percent over the same period. But, WhiteWave is not the...
-
Biogen And Gilead Sciences Buck Biotech Short Interest Trend
Sunday, June 12, 2016 - 2:35pm | 588Read More...Short interest in many of the leading biotech stocks shrank in the most recent period. Two stocks in particular stood out among the few that bucked the trend in those two weeks. Shares of both of these stocks rose sharply during the two-week period. Short sellers shied away from many of the...
-
GE And Other Companies In Transition That Insiders Are Buying
Monday, May 30, 2016 - 12:11pm | 607Read More...Insiders continue to snap up seeming bargains, even with the markets approaching highs. Three companies in transition saw notable insider purchases recently. Strong insider buying is often considered a positive sign for investors, particularly during volatile periods. Turnaround efforts at a...
-
Short Interest Surges In Illumina And Vertex Pharmaceuticals
Friday, May 13, 2016 - 1:26pm | 550Read More...Short interest in many of the leading biotech stocks shrank in the most recent period. Two stocks in particular stood out among the few that bucked the trend in those two weeks. Shares of one of those two stocks slumped more than 22 percent during the period. Short sellers shied away from many of...
-
Short Sellers Dump Vertex, Load Up On Baxalta
Thursday, April 28, 2016 - 8:34am | 588Read More...Short interest in many leading biotech stocks declined in the most recent period. Bucking that trend is a biotech company that soon will be acquired by an overseas peer. Short sellers retreated most sharply from a biotech that some analysts now see as a value stock. Between the March 31 and April...
-
Big Biotech In The Earnings Spotlight
Tuesday, April 26, 2016 - 8:08am | 735Read More...The three largest biotechs are set to share their latest quarterly results this week. Wall Street analysts are looking for solid to strong growth from all three. However, expectations are lower for many other biotech and pharmaceutical companies reporting this week. The three largest public...
-
Shire Still Confident In Baxalta Transaction Despite Treasury Headwinds
Wednesday, April 6, 2016 - 3:00pm | 262Read More...Shares of Shire PLC (ADR) (NASDAQ: SHPG) were trading higher by nearly 6 percent late Wednesday afternoon as the company issued a public comment regarding its proposed acquisition of Baxalta Inc (NYSE: BXLT). Ireland-based Shire said in a press release it still "anticipates" the...
-
Baxalta Submits Marketing Application For Adynovi In Europe, Shares Tick Higher
Wednesday, March 2, 2016 - 11:56am | 172Read More...Shares of Baxalta Inc (NYSE: BXLT) were trading higher by nearly 1 percent Wednesday after the company announced it has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for approval of its ADYNOVI. Baxalta completed a study in patients aged 12 to 16...
-
Shire CEO: Baxalta Deal 'Creates Significant Value' And Will Create The World's Leading Rare Disease Company 'By A Wide Margin'
Wednesday, January 13, 2016 - 10:33am | 238Read More...Shire PLC (ADR) (NASDAQ: SHPG)'s CEO, Flemming Ornskov was a guest on CNBC's "Closing Bell" on Tuesday to discuss the company's acquisition of Baxalta Inc (NYSE: BXLT). Ornskov said Shire's $32 billion acquisition of Baxalta is a "very good deal" and the...
-
Shire-Baxalta Combination Official, Shareholders Get $18 In Cash And Rest In Shares
Monday, January 11, 2016 - 9:35am | 375Read More...Shares of Shire PLC (ADR) (NASDAQ: SHPG) were trading higher by 1.80 percent at $189.34 early Monday morning while shares of Baxalta Inc (NYSE: BXLT) spiked higher by more than 5 percent at $42.20 after the companies confirmed a merger agreement. Shire and Baxalta announced on Monday morning that...
-
Merger Time? Baxalta Shares Rip After Shire Takeover Report
Thursday, January 7, 2016 - 4:07pm | 271Read More...Baxalta Inc (NYSE: BXLT) shares are up 3.4 percent on Thursday afternoon on the back of a newly issued Reuters report that calls for a merger with Shire PLC (ADR) (NASDAQ: SHPG) to be announced as soon as Monday. According to the outlet, Shire is preparing to unveil a $32.5 billion offer for...
-
UBS: Baxalta Is A Buy Even If Shire Buyout Doesn't Happen
Monday, January 4, 2016 - 6:15pm | 252Read More...Baxalta Inc (NYSE: BXLT) shares had a big Monday after a Bloomberg report of acquisition interest from Shire PLC (ADR) (NASDAQ: SHPG) hit wires over the weekend. According to the report, Shire is in advanced talks to buy Baxalta for about $32 billion in cash and stock excluding debt -- a per...
-
Report: Shire Close To Acquiring Baxalta, Cites Company's Revised Cash Offer
Tuesday, December 22, 2015 - 2:08pm | 167Read More...Shares of Baxalta Inc (NYSE: BXLT) surged higher early Tuesday afternoon after Reuters reported Shire PLC (ADR) (NASDAQ: SHPG) is now "closer" to acquiring the company. According to Reuters, Shire presented an acquisition offer to Baxalta that is "roughly in line" with...
-
Is Shire's $34 Billion Baxalta Acquisition Good For Shareholders? Most Think So
Wednesday, August 5, 2015 - 1:44pm | 595Read More...Shire PLC (ADR) (NASDAQ: SHPG) on Tuesday proposed a combination with Baxalta Inc (NYSE: BXLT) in a $30 billion all-stock deal, implying a potential value of $45.23 per Baxalta share. Here is a roundup of what Wall Street's top analysts are saying. Berenberg: Deal EPS Accretive...
